July 13, 2023

Get a strong start in oligonucleotide manufacturing




Oligonucleotide therapeutics hold incredible promise. How can you harness their full potential? When starting process development, you need to know where to focus, and you need a scalable and flexible solution. Building on 40 years of experience, Cytiva launched ӒKTA oligosynt™ benchtop oligo synthesizer in 2022. It is the newest member of our oligo synthesizer family – a family of oligo systems that scales from 10 μmol to 1800 mmol. You can find a solution that fits your needs in this family. Which oligo synthesizer is right for you?

Tags: Oligonucleotide synthesis, Oligonucleotide therapeutics, Oligonucleotide